SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Leerink Partners Raises Gilead Sciences Price Target to $145 From $129

Leerink Partners raised its price target on Gilead Sciences to $145 from $129.

GILD

Related stories